The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Icotinib as first-line or maintenance therapy in patients with advanced lung adenocarcinoma with positive EGFR mutation and the influence of cytokines shift on survival.
 
Shengjie Sun
No Relationships to Disclose
 
Shun Chang Jiao
No Relationships to Disclose
 
Jian Fang
No Relationships to Disclose
 
Qiong Sun
No Relationships to Disclose
 
Jindi Han
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Fenlai Tan
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Research Funding - Betta Pharmaceuticals
 
Lieming Ding
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Research Funding - Betta Pharmaceuticals